Global Invasive Fungal Infection (IFI) Market - Analysis By Disease Type, Pipeline Drugs, By Region, By Country (2020 Edition): Market Insight, Competition and Forecast (2019-2024)

Global Invasive Fungal Infection (IFI) Market - Analysis By Disease Type, Pipeline Drugs, By Region, By Country (2020 Edition): Market Insight, Competition and Forecast (2019-2024)

Executive Summary

Global Invasive Fungal Infection Market was valued at USD 6103.5 Million in the year 2018. The rise in population suffering from HIV/AIDS, discovery and advancement of pipeline drugs and facilities provided by hospitals in intensive care units for those who have undergone surgery, surge in chemotherapy and increase in use of broad spectrum antibiotics and global economic growth is going to accelerate the invasive fungal infection market. Introduction of advanced medicines has already proven to be constructive as it directly improves the health of immuno-compromised patient and enhances the life expectancy of a patient.

The Invasive Fungal Infection market has been estimated to witness growth in future primarily because of surging demand for low-cost pipeline products and increase in use of broad-spectrum antibiotics which makes fungi resistant to various medicines and to opt for the low-cost medicines whose effect can last longer than the traditional medicines.

A number of companies are offering variety of antibiotics which have decreased the resistance of several medicines, thus increasing the incidence of invasive fungal infection. In addition, rising investment by major leading Invasive Antifungal manufacturers in various regions with demand for effective and low cost product and focus of government on educating people about the care taken during the stay in ICU after undergoing solid organ transplantation with various government powered awareness programs that are being run with an aim to eradicate diseases, has been anticipated to spur the market growth during the forecast period.

Scope of the Report

  • There report analyzes the Global Invasive Fungal Infection Market By Diseases (Candidemia and invasive Candidiasis, Intra-abdominal candidiasis (Candida Peritonitis), Cryptococcal Meningitis, Histoplasmosis Disseminated, Histoplasmosis Acute Pulmonary, Invasive aspergillosis, Invasive Rhinosinusitis, Mucormycosis, Pneumocystis Pneumonia, Others).
  • The Global Invasive Fungal Infection Market has been analysed By Region (North America, Europe, Asia Pacific, ROW) and By Country (United States, Canada, Germany, France, United Kingdom, Spain, China, South Korea, Japan, India).
  • The key insights of the report have been presented through the frameworks of SWOT, Porter and Market Attractiveness charts. Market Attractiveness charts have been presented by diseases and by region. Additionally, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.
  • The report provides a detailed pipeline analysis of drugs being developed to cure the problem of Invasive Fungal Infection.
  • The report tracks competitive developments,market share analysis, strategies and new product development. The companies analysed in the report include Cidara, Basilea Pharmaceutica, Pfizer, GlaxoSmith Kline, Bayer AG, Abott, Merck & Co., Astellas Pharma Inc., F2G – The Rare Fungal Disease Company, Scynexis Inc
  • The report presents the analysis of Global Invasive Fungal Infection Market for the historical period of 2014-2018 and the forecast period of 2019-2024.
Key Target Audience
  • Pharmaceutical Companies
  • Consulting and Advisory Firms
  • Medical Practitioners
  • Regulatory Authorities


1. Report Scope and Methodology
1.1 Scope of the Report
1.2 Research Methodology
1.3 Executive Summary
2. Strategic Recommendations
2.1 Both Healthcare Providers and Public Health Agencies to Improve Diagnostics
2.2 Escalate the awareness among the population of APAC region
3. Global Invasive Fungal Infection Product Outlook
4. Global Invasive Fungal Infection Market: Sizing and Forecast
4.1 Market Size, By Value, Year 2014-2024
Table 1: Global Invasive Fungal Infection Market Size, By Value, 2014-2024 (USD Million)
Table 2: Global Prevalence of HIV, (%), 2013–2017
Table 3: Global Deaths by HIV, (%), 2013–2017
Table 4: Global Prevalence of Neoplasms (%), 2014–2016
Table 5: Global Prevalence of Tuberculosis (%), 2015–2017
5. Global Invasive Fungal Infection Market Segmentation By Diseases
5.1 Competitive Scenario of Global Invasive Fungal Infection Market: By Diseases
Table 6: Competitive Scenario of Global Fungal Infection Market- BY Diseases
5.2 Candidaemia and invasive candiasis – Market Size and Forecast (2019-2024)
Table 7: Global Invasive Fungal Infection Market- By Candidemia and invasive candiasis, By Value (USD Million), 2014-2024
5.3 Intra-abdominal Candiasis (Candida Peritonitis) - Market Size and Forecast (2019-2024)
Table 8: Global Invasive Fungal Infection Market- By Intra-abdominal Candiasis (Candida Peritonitis), By Value (USD Million), 2014-2024
5.4 Cryptococcal Meningitis – Market Size and Forecast (2019-2024)
Table 9: Global Invasive Fungal Infection Market- By Cryptococcal Meningitis , By Value (USD Million), 2014-2024
5.5 Histoplasmosis Disseminated- Market Size and Forecast (2019-2024)
Table 10: Global Invasive Fungal Infection Market- By Histoplasmosis Disseminated, By Value (USD Million), 2014-2024
5.6 Histoplasmosis acute pulmonary – Market Size and Forecast (2019-2024)
Table 11: Global Invasive Fungal Infection Market- By Histoplasmosis acute pulmonary, By Value (USD Million), 2014-2024
5.7 Invasive Aspergillosis - Market Size and Forecast (2019-2024)
Table 12: Global Invasive Fungal Infection Market- By Invasive Aspergillosis, By Value (USD Million), 2014-2024
5.8 Invasive Rhinosinusitis – Market Size and Forecast (2019-2024)
Table 13: Global Invasive Fungal Infection Market- By Invasive Rhinosinusitis, By Value (USD Million), 2014-2024
5.9 Mucormycosis - Market Size and Forecast (2019-2024)
Table 14: Global Invasive Fungal Infection Market- By Mucormycosis, By Value (USD Million), 2014-2024
5.10 Pneumocystis Pneumonia - Market Size and Forecast (2019-2024)
Table 15: Global Invasive Fungal Infection Market- By Pneumocystis Pneumonia, By Value (USD Million), 2014-2024
5.11 Others – Market Size and Forecast (2019-2024)
Table 16: Global Invasive Fungal Infection Market- By Others, By Value (USD Million), 2014-2024
6. Global Invasive Fungal Infection Market: Regional Analysis
6.1 Competitive Scenario of Global Invasive Fungal Infection: By Region
Table 17: Competitive Scenario of Global Invasive Fungal Infection- By Region
7. North America Invasive Fungal Infection Market: Segmentation By Diseases (2019-2024)
7.1 North America Invasive Fungal Infection Market: Size and Forecast (2019-2024)
Table 18: North America Invasive Fungal Infection Market Size, By Value, 2014-2024 (USD Million)
Table 19: North America Prevalence of HIV, (%), 2013–2017
Table 20: North America Deaths by HIV, (%), 2013–2017
Table 21: North America Prevalence of Neoplasms (%), 2013–2017
Table 22: North America Prevalence of Tuberculosis (%), 2012–2017
7.2 North America Invasive Fungal Infection Market – Prominent Companies
Table A Prominent Invasive Fungal Infection Companies Operating in North America Market
7.3 Market Segmentation By Product Type- (Diseases)
7.4 Market Segmentation By Diseases- (Candidemia and invasive candiasis, Intra-abdominal Candiasis (Candida Peritonitis), Cryptococcal Meningitis , Histoplasmosis Disseminated, Histoplasmosis acute Pulmonary, Invasive Aspergillosis, Invasive Rhinosinusitis, Mucormycosis, Pneumocystis Pneumonia, Others)
Table 23: North America Invasive Fungal Infection Market, By Diseases, By Value (USD Million), 2014-2024
Table 24: North America Invasive Fungal Infection Market- By Diseases, By Value (USD Million), 2014-2024
7.5 North America Invasive Fungal Infection Market: Country Analysis
7.6 Market Opportunity Chart of North America Invasive Fungal Infection Market - By Country, By Value
(Year-2024)
Table 25: Market Opportunity Chart of North America Invasive Fungal Infection Market - By Country, By Value (Year-2024)
7.7 Competitive Scenario of North America Invasive Fungal Infection: By Country
Table 26: Competitive Scenario of North America Invasive Fungal Infection- By Country
7.8 United States Invasive Fungal Infection Market Size, By Value, 2014-2024 (USD Million)
Table 27: United States Invasive Fungal Infection Market Size, By Value, 2014-2024 (USD Million)
Table 28: US Prevalence of HIV, (%), 2013–2017
Table 29: US Deaths by HIV, (%), 2013–2017
Table 30: US Prevalence of Neoplasms (%), 2014–2016
Table 31: US Prevalence of Tuberculosis (%), 2012–2017
7.9 United States Invasive Fungal Infection Market Segmentation- By Diseases
Table 32: United States Invasive Fungal Infection Market- By Diseases, By Value (USD Million), 2014-2024
Table 33: United States Invasive Fungal Infection Market- By Diseases, By Value (USD Million), 2014-2024
7.10 Canada Invasive Fungal Infection Market: Size and Forecast (2019-2024)
Table 34: Canada Invasive Fungal Infection Market Size, By Value, 2014-2024 (USD Million)
Table 35: Canada Prevalence of HIV, (%), 2013–2017
Table 36: Canada Deaths by HIV, (%), 2013–2017
Table 37: Canada Prevalence of Neoplasms (%), 2014–2016
Table 38: Canada Prevalence of Tuberculosis (%), 2012–2017)
7.11 Canada Invasive Fungal Infection Market Segmentation- By Diseases
Table 39: Canada Invasive Fungal Infection Market- By Diseases(USD Million), 2014-2024
Table 40: Canada Invasive Fungal Infection Market- By Diseases, By Value (USD Million), 2014-2024
8. Europe Invasive Fungal Infection Market: Segmentation By Diseases (2019-2024)
8.1 Market Opportunity Chart of Europe Invasive Fungal Infection Market - By Country, By Value
(Year-2024)
Table 41: Market Opportunity Chart of Europe Invasive Fungal Infection Market - By Country, By Value (Year 2024)
8.2 Competitive Scenario of Europe Invasive Fungal Infection: By Country
Table 42: Competitive Scenario of Europe Invasive Fungal Infection – By Country
8.3 Europe Invasive Fungal Infection Market: Size and Forecast (2019-2024)
Table 43: Europe Invasive Fungal Infection Market Size, By Value, 2014-2024 (USD Million)
Table 44: Europe Prevalence of HIV, (%), 2013–2017
Table 45: Europe Deaths by HIV, (%), 2013–2017
Table 46: Europe Prevalence of Neoplasms (%), 2013–2017
Table 47: Europe Prevalence of Tuberculosis (%), 2012–2017
8.4 Europe Invasive Fungal Infection Market – Prominent Companies
Table B Prominent Invasive Fungal Infection Companies Operating in Europe Market
8.5 Market Segmentation By Diseases- (Candidaemia and invasive candiasis, Intra-abdominal Candiasis (Candida Peritonitis), Cryptococcal Meningitis , Histoplasmosis Disseminated, Histoplasmosis acute Pulmonary, Invasive Aspergillosis, Invasive Rhinosinusitis, Mucormycosis, Pneumocystis Pneumonia, Others)
Table 48: Europe Invasive Fungal Infection Market- By Diseases(USD Million), 2014-2024
Table 49: Europe Invasive Fungal Infection Market- By Diseases, By Value (USD Million), 2014-2024
8.6 Europe Invasive Fungal Infection Market: Country Analysis
8.7 Germany Invasive Fungal Infection Market: Size and Forecast (2019-2024)
Table 50: Germany Invasive Fungal Infection Market Size, By Value, 2014-2024 (USD Million)
Table 51: Germany Prevalence of HIV, (%), 2013–2017
Table 52: Germany Deaths by HIV, (%), 2013–2017)
Table 53: Germany Prevalence of Neoplasms (%), 2013–2017
Table 54: Germany Prevalence of Tuberculosis (%), 2012–2017
8.8 Germany Invasive Fungal Infection Market Segmentation- By Diseases
Table 55: Germany Invasive Fungal Infection Market, By Diseases, By Value (USD Million), 2014-2024
Table 56: Germany Invasive Fungal Infection Market- By Diseases, By Value (USD Million), 2014-2024
8.9 France Invasive Fungal Infection Market: Size and Forecast (2019-2024)
Table 57: France Invasive Fungal Infection Market Size, By Value, 2014-2024 (USD Million)
Table 58: France Prevalence of HIV, (%), 2013–2017
Table 59: France Deaths by HIV, (%), 2013–2017
Table 60: France Prevalence of Neoplasms (%), 2013–2017
Table 61: France Prevalence of Tuberculosis (%), 2012–2017
8.10 France Invasive Fungal Infection Market Segmentation- By Diseases
Table 62: France Invasive Fungal Infection Market, By Diseases, By Value (USD Million), 2014-2024
Table 63: France Invasive Fungal Infection Market- By Diseases, By Value (USD Million), 2014-2024
8.11 United Kingdom Invasive Fungal Infection Market: Size and Forecast (2019-2024)
Table 64: United Kingdom Invasive Fungal Infection Market Size, By Value, 2014-2024 (USD Million)
Table 65: UK Prevalence of HIV, (%), 2013–2017
Table 66: UK Deaths by HIV, (%), 2013–2017
Table 67: UK Prevalence of Neoplasms (%), 2013–2017
Table 68: UK Prevalence of Tuberculosis (%), 2012–2017
8.12 United Kingdom Invasive Fungal Infection Market Segmentation- By Diseases
Table 69: United Kingdom Invasive Fungal Infection Market- By Diseases, By Value (USD Million), 2014-2024
Table 70: United Kingdom Invasive Fungal Infection Market- By Diseases, By Value (USD Million), 2014-2024
8.13 Spain Invasive Fungal Infection Market: Size and Forecast (2019-2024)
Table 71: Spain Invasive Fungal Infection Market Size, By Value, 2014-2024 (USD Million)
Table 72: Spain Prevalence of HIV, (%), 2013–2017
Table 73: Spain Deaths by HIV, (%), 2013–2017
Table 74: Spain Prevalence of Neoplasms (%), 2013–2017
Table 75: Spain Prevalence of Tuberculosis (%), 2012–2017
8.14 Spain Invasive Fungal Infection Market Segmentation- By Diseases
Table 76: Spain Invasive Fungal Infection Market, By Diseases, By Value (USD Million), 2014-2024
Table 77: Spain Invasive Fungal Infection Market- By Diseases, By Value (USD Million), 2014-2024
8.15 Rest of Europe Invasive Fungal Infection Market: Size and Forecast (2019-2024)
Table 78: Rest of Europe Invasive Fungal Infection Market Size, By Value, 2014-2024 (USD Million)
8.16 Rest of Europe Invasive Fungal Infection Market Segmentation- By Product Type, End User
Table 79: Rest of Europe Invasive Fungal Infection Market- By Diseases, By Value (USD Million), 2014-2024
Table 80: Rest of Europe Invasive Fungal Infection Market- By Diseases, By Value (USD Million), 2014-2024
9. Asia Pacific Invasive Fungal Infection Market: Segmentation By Diseases (2019-2024)
9.1 Market Opportunity Chart of Asia Pacific Invasive Fungal Infection Market - By Country, By Value (Year-2024)
Table 81: Market Opportunity Chart of APAC Invasive Fungal Infection Market – By Country, By Value
9.2 Competitive Scenario of Asia Pacific Invasive Fungal Infection: By Country
Table 82: Competitive Scenario of APAC Invasive Fungal Infection – By Country
9.3 Asia Pacific Invasive Fungal Infection Market: Size and Forecast (2019-2024)
Table 83: APAC Invasive Fungal Infection Market Size, By Value, 2014-2024 (USD Million)
Table 84: Asia Prevalence of HIV, (%), 2013–2017
Table 85: Asia Deaths by HIV, (%), 2013–2017
Table 86: Asia Prevalence of Neoplasms (%), 2013–2017
Table 87: Asia Prevalence of Tuberculosis (%), 2012–2017
9.4 Asia Pacific Invasive Fungal Infection Market – Prominent Companies
Table C Prominent Invasive Fungal Infection Companies Operating in APAC Market
9.5 Market Segmentation By Diseases- (Candidaemia and invasive candiasis, Intra-abdominal Candiasis (Candida Peritonitis), Cryptococcal Meningitis , Histoplasmosis Disseminated, Histoplasmosis acute Pulmonary, Invasive Aspergillosis, Invasive Rhinosinusitis, Mucormycosis, Pneumocystis Pneumonia, Others)
Table 88: APAC Invasive Fungal Infection Market- By Diseases, By Value (USD Million), 2014-2024
Table 89: APAC Invasive Fungal Infection Market- By Diseases, By Value (USD Million), 2014-2024
9.6 Asia Pacific Invasive Fungal Infection Market: Country Analysis
9.7 China Invasive Fungal Infection Market: Size and Forecast (2019-2024)
Table 90: China Invasive Fungal Infection Market Size, By Value, 2014-2024 (USD Million)
Table 91: China Prevalence of HIV, (%), 2013–2017
Table 92: China Deaths by HIV, (%), 2013–2017
Table 93: China Prevalence of Neoplasms (%), 2013–2017
Table 94: China Prevalence of Tuberculosis (%), 2012–2017
9.8 China Invasive Fungal Infection Market Segmentation- By Diseases
Table 95: China Invasive Fungal Infection Market- By Diseases, By Value (USD Million), 2014-2024
Table 96: China Invasive Fungal Infection Market- By Diseases, By Value (USD Million), 2014-2024
9.9 South Korea Invasive Fungal Infection Market: Size and Forecast (2019-2024)
Table 97: South Korea Invasive Fungal Infection Market Size, By Value, 2014-2024 (USD Million)
Table 98: South Korea Prevalence of HIV, (%), 2013–2017
Table 99: South Korea Deaths by HIV, (%), 2013–2017
Table 100: South Korea Prevalence of Neoplasms (%), 2013–2017
Table 101: South Korea Prevalence of Tuberculosis (%), 2012–2017
9.10 South Korea Invasive Fungal Infection Market Segmentation- By Diseases
Table 102: South Korea Invasive Fungal Infection Market, By Diseases, By Value (USD Million), 2014-2024
Table 103: South Korea Invasive Fungal Infection Market, By Diseases, By Value (USD Million), 2014-2024
9.11 Japan Invasive Fungal Infection Market: Size and Forecast (2019-2024)
Table 104: Japan Invasive Fungal Infection Market Size, By Value, 2014-2024 (USD Million)
Table 105: Japan Prevalence of HIV, (%), 2013–2017
Table 106: Japan Incidence of HIV, (%), 2013–2017
Table 107: Japan Prevalence of Neoplasms (%), 2013–2017
Table 108: Japan Prevalence of Tuberculosis (%), 2012–2017
9.12 Japan Invasive Fungal Infection Market Segmentation- By Diseases
Table 109: Japan Invasive Fungal Infection Market, By Diseases, By Value (USD Million), 2014-2024
Table 110: Japan Invasive Fungal Infection Market, By Diseases, By Value (USD Million), 2014-2024
9.13 India Invasive Fungal Infection Market: Size and Forecast (2019-2024)
Table 111: India Invasive Fungal Infection Market Size, By Value, 2014-2024 (USD Million)
Table 112: India Prevalence of HIV, (%), 2013–2017
Table 113: India Incidence of HIV, (%), 2013–2017
Table 114: India Prevalence of Neoplasms (%), 2013–2017
Table 115: India Prevalence of Tuberculosis (%), 2012–2017
9.14 India Invasive Fungal Infection Market Segmentation- By Diseases
Table 116: India Invasive Fungal Infection Market, By Diseases, By Value (USD Million), 2014-2024
Table 117: India Invasive Fungal Infection Market, By Diseases, By Value (USD Million), 2014-2024
9.15 Rest of Asia Pacific Invasive Fungal Infection Market: Size and Forecast (2019-2024)
Table 118: Rest of APAC Invasive Fungal Infection Market Size, By Value, 2014-2024 (USD Million)
9.16 Rest of Asia Pacific Invasive Fungal Infection Market Segmentation- By Diseases
Table 119: Rest of APAC Invasive Fungal Infection Market, By Diseases, By Value (USD Million), 2014-2024
Table 120: Rest of APAC Invasive Fungal Infection Market, By Diseases, By Value (USD Million), 2014-2024
10. Rest of the World Invasive Fungal Infection Market: Segmentation By Diseases (2019-2024)
10.1 Market Opportunity Chart of Rest of the World Invasive Fungal Infection Market - By Country, By Value
(Year-2024)
Table 121: Market Opportunity Chart of North America Invasive Fungal Infection Market - By Country, By Value (Year 2024)
10.2 Competitive Scenario of Rest of the World Invasive Fungal Infection: By Country
Table 122: Competitive Scenario of Rest of the World Invasive Fungal Infection – By Country
10.3 Rest of the World Invasive Fungal Infection Market: Size and Forecast (2019-2024)
Table 123: Rest of the World Invasive Fungal Infection Market Size, By Value, 2014-2024 (USD Million)
10.4 Market Segmentation By Diseases- (Candidaemia and invasive candiasis, Intra-abdominal Candiasis (Candida Peritonitis), Cryptococcal Meningitis , Histoplasmosis Disseminated, Histoplasmosis acute Pulmonary, Invasive Aspergillosis, Invasive Rhinosinusitis, Mucormycosis, Pneumocystis Pneumonia, Others)
Table 124: ROW Invasive Fungal Infection Market, By Diseases, By Value (USD Million), 2014-2024
Table 125: ROW Invasive Fungal Infection Market, By Diseases, By Value (USD Million), 2014-2024
10.5 Rest of the World Invasive Fungal Infection Market: Country Analysis
10.6 Brazil Invasive Fungal Infection Market: Size and Forecast (2019-2024)
Table 126: Brazil Invasive Fungal Infection Market Size, By Value, 2014-2024 (USD Million)
Table 127: Brazil Prevalence of HIV, (%), 2013–2017
Table 128: Brazil deaths of HIV, (%), 2013–2017
Table 129: Brazil Prevalence of Neoplasms (%), 2013–2017
Table 130: Brazil Prevalence of Tuberculosis (%), 2012–2017
10.7 Brazil Invasive Fungal Infection Market Segmentation- By Diseases
Table 131: Brazil Invasive Fungal Infection Market, By Diseases, By Value (USD Million), 2014-2024
Table 132: Brazil Invasive Fungal Infection Market, By Diseases, By Value (USD Million), 2014-2024
10.8 Egypt Invasive Fungal Infection Market: Size and Forecast (2019-2024)
Table 133: Egypt Invasive Fungal Infection Market Size, By Value, 2014-2024 (USD Million)
Table 134: Egypt Prevalence of HIV, (%), 2013–2017
Table 135: Egypt Incidence of HIV, (%), 2013–2017
Table 136: Egypt Prevalence of Neoplasms (%), 2013–2017
Table 137: Egypt Prevalence of Tuberculosis (%), 2012–2017
10.9 Egypt Invasive Fungal Infection Market Segmentation- By Diseases
Table 138: Egypt Invasive Fungal Infection Market, By Diseases, By Value (USD Million), 2014-2024
Table 139: Egypt Invasive Fungal Infection Market, By Diseases, By Value (USD Million), 2014-2024
10.10 Rest of the Countries Invasive Fungal Infection Market: Size and Forecast (2019-2024)
Table 140: Rest of the Countries Invasive Fungal Infection Market Size, By Value, 2014-2024 (USD Million)
10.11 Rest of the Countries Invasive Fungal Infection Market Segmentation- By Diseases
Table 141: Rest of the Countries Invasive Fungal Infection Market, By Diseases, By Value (USD Million), 2014-2024
Table 142: Rest of the Countries Invasive Fungal Infection Market, By Diseases, By Value (USD Million), 2014-2024
11. Global Invasive Fungal Infection Market Dynamics
11.1 Global Invasive Fungal Infection Market Drivers
11.2 Global Invasive Fungal Infection Market Restraints
11.3 Global Invasive Fungal Infection Market Trends
12. Strategic Analysis
12.1 Development of Pipeline Products
13. Market Attractiveness
13.1.1 Market Attractiveness Chart of Global Invasive Fungal Infection Market - By Diseases(Year 2024)
Table 143: Market Attractiveness Chart of Global Invasive Fungal Infection Market - By Diseases (Year-2024)
13.1.2 Market Attractiveness Chart of Global Invasive Fungal Infection Market - By Region (Year 2024)
Table 144: Market Attractiveness Chart of Global Invasive Fungal Infection Market – By Region, By Value, (Year-204)
14. Competitive Landscape
14.1 Market Share Analysis
Table 145: Competitive Positions of Invasive Fungal Infection Companies (2018)
14.2 SWOT Analysis
14.3 Porter’s Five Force Analysis
15. Company Profiles (Business Description, Financial Analysis, Business Strategy)
15.1 Cidara Therapeutics
Table 146: Cidara Therapeutics, Research and Development 2016-2018 (In USD Million)
Table 147: Cidara Therapeutics, Research and Development By Product Category, 2018 (In %)
15.2 Basilea Pharmaceutica
Table 148: Basilea Revenue, 2014-2018 (In USD Billion)
Table 149: Basilea Revenue, By Region, 2017 (In %)
Table 150: Basilea Revenue, By Region, 2018 (In %)
15.3 Pfizer
Table 151: Pfizer Revenue, 2014 - 2018 (In USD Billion)
Table 152: Pfizer Sales Revenue, By Region, 2017 (In %)
Table 153: Pfizer Sales Revenue, By Region, 2018 (In %)
Table 154: Pfizer Revenue, By Business Segment, 2017, 2018 (In USD Million)
Table 155: Pfizer Revenue, By IH Segment, By Region 2018 (In %)
Table 156: Pfizer Revenue, By EH Segment, By Region 2018 (In %)
15.4 GlaxoSmithKline
Table 157: GSK, Turnover, 2014 - 2018 (In USD Billion)
Table 158: GSK, Turnover, By Segments, 2017 (In %)
Table 159: GSK, Turnover, By Segments, 2018 (In %)
Table 160: GSK, Turnover, By Geographic Region, 2017 (In %)
Table 161: GSK, Turnover, By Geographic Region, 2018 (In %)
15.5 Bayer AG
Table 162: Bayer AG, Sales Revenue, 2014 - 2018 (In USD Million)
Table 163: Bayer AG, Net Sales Revenue, By Region, 2017 (In %)
Table 164: Bayer AG, Net Sales Revenue, By Region, 2018 (In %)
15.6 Abbott
Table 165: Abbott Net Income, 2014 - 2018 (In USD Million)
Table 166: Abbott Sales Revenue, By Business Segment, 2017 (In %)
Table 167: Abbott Sales Revenue, By Business Segment, 2018 (In %)
Table 168: Abbott Sales, By Geographic Region, 2017 (In %)
Table 169: Abbott Sales, By Geographic Region, 2018 (In %)
15.7 Merck & Co
Table 170: Merck & Co, Sales, 2014 - 2018 (In USD Million)
Table 171: Merck & Co, Sales Revenue, By Business Segment, Hospital Acute Care 2017 (In %)
Table 172: Merck & Co, Sales Revenue, By Business Segment, Hospital Acute Care 2018 (In %)
Table 173: Merck & Co, Sales, By Geographic Region, 2017 (In %)
Table 174: Merck & Co, Sales, By Geographic Region, 2018 (In %)
15.8 Astellas Pharma Inc.
Table 174 Astellas Pharma Inc., Sales, 2014 - 2018 (In USD Billion)
Table 176: Astellas Pharma Inc., Sales Revenue, By Product, 2018 (In USD Billion)
Table 177: Astellas Pharma Inc., Sales Revenue, By Product, 2019 (In USD Billion)
Table 178: Astellas Pharma Inc. , Sales, By Geographic Region, 2017 (In %)
Table 179: Astellas Pharma Inc. , Sales, By Geographic Region, 2018 (In %)
15.9 F2G- the Rare Fungal Disease Company
15.10 Scynexis Inc.
Table 180: Scynexis Inc., Revenue, 2014 - 2018 (In USD Thousands)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook